TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $525,000 | -28.2% | 11,002 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $731,000 | -14.8% | 11,002 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $858,000 | -17.6% | 11,002 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $1,041,000 | -26.5% | 11,002 | -5.4% | 0.01% | -28.6% |
| Q4 2020 | $1,417,000 | +14.7% | 11,632 | -17.7% | 0.01% | 0.0% |
| Q3 2020 | $1,235,000 | +35.3% | 14,133 | 0.0% | 0.01% | +27.3% |
| Q2 2020 | $913,000 | +40.7% | 14,133 | -2.8% | 0.01% | +22.2% |
| Q1 2020 | $649,000 | – | 14,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |